← Back to Search

Bandage Comparison for Pilonidal Disease

Phase 4
Waitlist Available
Led By Michael P McNally, M.D.
Research Sponsored by Walter Reed National Military Medical Center
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Post-surgical wound measurement (length x width x depth) greater than or equal to 3 cm in length, greater than or equal to 1.5 cm in width, and greater than or equal to 1.5 cm in depth. Rationale: satisfies the minimum size wound that NPWT may be employed
Healthy adult male or non-lactating female age 18 to 60 years inclusive
Timeline
Screening 3 weeks
Treatment Varies
Follow Up up to 270 days or 9 months
Awards & highlights

Study Summary

This trial is comparing two types of bandages to see which one helps pilonidal cyst wounds heal faster after surgery.

Who is the study for?
Adults aged 18-60 with pilonidal disease needing surgery can join this study. They must score well on a knowledge test about the study, be available for its duration, and consent to participate. Smokers, those with complex pilonidal disease or certain health conditions like autoimmune diseases or diabetes are excluded.Check my eligibility
What is being tested?
The trial is testing two types of dressings: Drawtex dressing and Negative Pressure Wound Therapy (NPWT), to see which one helps wounds heal faster after pilonidal cyst surgery. Participants will be assigned to one of these treatments post-surgery.See study design
What are the potential side effects?
Potential side effects may include discomfort at the wound site, skin irritation from the dressings, and possible infection risks associated with wound care procedures.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
My surgical wound is at least 3 cm long, 1.5 cm wide, and 1.5 cm deep.
Select...
I am a healthy adult between 18 and 60 years old and not breastfeeding.
Select...
I need surgery for a pilonidal cyst that involves removing the cyst and some surrounding area.
Select...
I have chronic pilonidal disease with frequent abscesses or symptoms affecting my daily life.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~up to 270 days or 9 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and up to 270 days or 9 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Time to wound healing

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Drawtex Hydroconductive DressingExperimental Treatment1 Intervention
Gauze-like dressing placed onto wound
Group II: Negative Pressure Wound TherapyActive Control1 Intervention
Usual care including vacuum and canister
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Drawtex dressing
2010
N/A
~10

Find a Location

Who is running the clinical trial?

Walter Reed National Military Medical CenterLead Sponsor
137 Previous Clinical Trials
34,467 Total Patients Enrolled
United States Department of DefenseFED
861 Previous Clinical Trials
227,164 Total Patients Enrolled
Michael P McNally, M.D.Principal InvestigatorDepartment of General Surgery

Media Library

Surgery Clinical Trial Eligibility Overview. Trial Name: NCT01857128 — Phase 4
Pilonidal Disease Research Study Groups: Drawtex Hydroconductive Dressing, Negative Pressure Wound Therapy
Pilonidal Disease Clinical Trial 2023: Surgery Highlights & Side Effects. Trial Name: NCT01857128 — Phase 4
Surgery 2023 Treatment Timeline for Medical Study. Trial Name: NCT01857128 — Phase 4

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Does the criteria for this clinical trial include individuals under thirty years of age?

"According to the conditions for inclusion, participants must be aged 18 up to 60. Additionally, there are additional studies available for children and elderly individuals over the age of 65."

Answered by AI

Who is eligible to enroll in this medical research program?

"To qualify for this research, individuals must possess a diagnosis of pilonidal disease and be between the ages 18-60. This trial is actively seeking 30 participants."

Answered by AI

Has Drawtex dressing obtained endorsement from the Federal Drug Administration?

"Evaluated to be a 3 on the safety scale, Drawtex dressing has been approved for use in Phase 4 trials."

Answered by AI

Are there currently any open opportunities to participate in this clinical trial?

"The clinicaltrials.gov website states that this medical trial, which was posted on March 1st 2013 and last modified 17th May of the same year, is not actively recruiting patients at present. Nevertheless, 4 other studies are currently in search for participants."

Answered by AI
~2 spots leftby Apr 2025